Next Article in Journal
Physiological Responses at 15 Minutes of Recovery after a Session of Functional Fitness Training in Well-Trained Athletes
Previous Article in Journal
Association between Leptin (G2548A) and Leptin Receptor (Q223R) Polymorphisms with Plasma Leptin, BMI, Stress, Sleep and Eating Patterns among the Multiethnic Young Malaysian Adult Population from a Healthcare University
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Examine Race/Ethnicity Disparities in Perception, Intention, and Screening of Dementia in a Community Setting: Scoping Review

Nursing Department, Robert and Donna Manning College of Nursing and Health Sciences, University of Massachusetts Boston, Boston, MA 02125, USA
*
Author to whom correspondence should be addressed.
Int. J. Environ. Res. Public Health 2022, 19(14), 8865; https://doi.org/10.3390/ijerph19148865
Submission received: 18 May 2022 / Revised: 7 July 2022 / Accepted: 14 July 2022 / Published: 21 July 2022

Abstract

:
Background: Delayed detection and diagnosis of Alzheimer’s Disease and related dementia (ADRD) can lead to suboptimal care and socioeconomic burdens on individuals, families, and communities. Our objective is to investigate dementia screening behavior focusing on minority older populations and assess whether there are ethnic differences in ADRD screening behavior. Methods: The scoping review method was utilized to examine ADRD screening behavior and contributing factors for missed and delayed screening/diagnosis focusing on race/ethnicity. Results: 2288 papers were identified, of which 21 met the inclusion criteria. We identified six dimensions of ADRD screening behavior: Noticing Symptoms, Recognizing a problem, Accepting Screen, Intending Screen, Action, and Integrating with time. Final findings were organized into study race/ethnicity, theoretical background, the methods of quantitative and qualitative studies, description and measures of ADRD screening behavior, and racial/ethnic differences in ADRD screening behavior. Conclusions: A trend in ethnic disparities in screening for ADRD was observed. Our findings point to the fact that there is a scarcity of studies focusing on describing ethnic-specific ADRD screening behavior as well as a lack of those examining the impact of ethnicity on ADRD screening behavior, especially studies where Asian Americans are almost invisible.

1. Introduction

According to an annual report of the Alzheimer’s Association, more than six million Americans live with Alzheimer’s disease and related dementia (ADRD). Between 2000 and 2019, one in three seniors died from ADRD, while the number of deaths from heart disease decreased by 7.3% [1]. Currently, more than 55 million people live with dementia globally, and there are nearly 10 million new cases every year. The magnitude of health economics and the human and social impact on individuals living with dementia, their families, communities, and society are drastically increasing. It is estimated that the global cost of dementia could grow to US$2 trillion by 2030.
Although there are currently no specific treatments to block the progression of cognitive decline in ADRD, an early diagnosis helps patients and families to plan for their future care and treatment. However, dementia is substantially underdiagnosed by clinicians and underreported by patients and families in the U.S., and studies have found that 40 percent to more than half of patients with dementia had not received a clinical cognitive evaluation by a physician [2,3,4]. Moreover, according to Healthy People 2020, baseline data show that, even among those diagnosed with dementia, nearly two-thirds of them or their caregivers were aware of the diagnosis [5]. Studies show that racial/ethnic disparities in misdiagnosis and the problem of underdiagnosis are even more pronounced in underserved populations and those with low socioeconomic status (SES) [6,7,8,9,10,11]. In the same vein, evidence points to the fact that, at first dementia diagnosis, racial/ethnic minorities are more impaired and show more severe clinical symptoms, which may suggest that diagnosis occurs at a later stage of the disease for these groups [12,13]. The older population is becoming more racially and ethnically diverse. Between 2014 and 2060, the share of the older non-Hispanic white population is projected to drop by 24 percentage points, from 78.3 percent to 54.6 percent, in the U.S.; therefore, a higher percentage of people with ADRD will be minorities [14]. The literature supports the need for studies exploring and explaining the impact of the ethnoracial factors on ADRD, not only genetic and biological factors, but also sociocultural factors related to the timing of diagnosis, lay symptom recognition, lay diagnosis and course of AD between different ethnocidal groups [15,16].
Differences in dementia screening behavior from both healthcare professionals and patients or patient families can be expected as a function of the ethnoracial factors because the ethnoracial groups are characterized by distinct social and behavioral practices [16,17]. Several factors related to dementia screening and diagnosis, including the individual level of health belief, sociocultural norms, and access to healthcare services among elderly minority populations, pose special challenges in dementia diagnosis and treatment [16,17,18,19,20,21]. However, there is scarce information on the extent of understanding dementia screening behavior among ethnic minorities. Understanding dementia screening behavior and race/ethnicity as influencing the proportion of detected and undetected dementia is important for improving dementia screening/diagnosing behaviors and moving to equity of ADRD management.
This review aims to investigate dementia screening behavior among minority older populations and whether there are any racial/ethnic differences in screening behaviors. Thus, we only reviewed studies that addressed ADRD screening/diagnosing behavior among ethnic/racial minorities in North America versus reports of screening/diagnosis rates.

2. Materials and Methods

We adopted the Preferred Reporting Items for Systematic Reviews and Meta-analyses extension for Scoping Reviews (PRISMA-ScR) [22]. A scoping review uses systematic and rigorous methods and summarizes the findings from the body of knowledge that is heterogeneous in methods including both quantitative and qualitative designs or disciplines [22,23,24,25,26,27]. The difference from a systematic review is that a scoping review does not have a specific research question, but rather seeks to provide a broad overview of the available literature and identify gaps in the literature [24,26]. Our protocol was drafted using both PRISMA-ScR and Arksey and O’Malley’s scoping review guidelines [22,23,24,25]. No ethical approval is required for this type of study.

2.1. Search Strategy and Study Selection

The search strategy included databases, search terms, and inclusion/exclusion criteria. Three databases (PubMed, Cumulative Index to Nursing and Allied Health Literature (CINAHL), and PsycINFO) were used to search for the most relevant literature. Search terms to find published studies that reported on factors associated with dementia screening behaviors were determined through several discussions with a university librarian: “dementia screening”, “Alzheimer’s disease screening”, “barriers”, “delayed”, “facilitators”, factors”, “pathway”, “race”, “ethnicity”, “minorities”, “Asian American”, “Black/African American”, “Hispanic”, “Latino/a”, and “Native American”, combined with the Boolean operator “AND/OR.” The publication year of the literature was restricted from 2000 onwards because the number of deaths from Alzheimer’s disease (AD) has increased by more than 145% from 2000 to 2019 in the U.S. [1]. One of the authors (H.L.) who designed this study recommended several studies of examples that might be included in the literature. An additional database search for more studies targeting Asian Americans was conducted. For this search, the university librarian designed additional search terms as follows: “Chinese American”, “Filipino American”, “Asian Indian American”, “Korean American”, “Vietnamese American”, and “Japanese American”, which are the five largest Asian American subgroups.
Prior to the initiation of screening, duplicate records were removed. After duplicates were removed, articles retrieved from the databases and the author’s recommendations were screened for their titles, abstracts, and full texts to determine their eligibility. Only empirical articles with an English abstract were included. Since the aim of the scoping review is to provide a broad overview of relevant studies, we considered all types of research design. We applied the following inclusion criteria at two stages of study selection (screening by title and abstract, and then full text). Inclusion criteria involved: (a) use of primary data reporting factors relative to ADRD screening behaviors, (b) conducted in North America (the U.S. or Canada), (c) covering the older adult population, (d) published in English, and (e) full text available. Excluded criteria were studies: (a) focused on countries outside North America, (b) did not measure ADRD screening behavior, and (c) did not report any data for minority populations as this study sought to examine dementia screening behavior among the ethnic minority older adult population and there are any disparities in dementia screening.
To increase consistency among reviewers, three researchers (H.L., S.L., D.K.) independently performed screening by assigning studies to “include,” “exclude,” or “not sure” categories and discussed the results. Discrepancies among researchers were resolved through discussion, and the screening and data extraction guidance was revised.
Lastly, reference lists of included studies were hand searched and screened to ensure the complete inclusion of relevant studies. Final decisions about the inclusion of studies were made upon the discussion and agreement between researchers. Figure 1 presents the process diagram indicating the search process.

2.2. Data Extraction

Each full text of the included studies was critically assessed to extract data. Data were extracted using a standardized data extraction table that the research team developed, including (a) characteristics such as design, research setting, and ethnicity of participants, (b) theory or framework, (c) dementia screening behaviors, (d) measures, and (e) major findings and discussion. Three reviewers jointly developed a data-charting form to determine which variable to extract. The two reviewers (S.L. and D.K.) independently charted the data, discussed the results, and continuously updated the data charting in an interactive process. These data were extracted by two researchers (S.L. and D.K.) and then examined and agreed upon by the PI (H.L.) to ensure validity.

2.3. Collecting and Summarization

The scoping review findings of the literature are documented in Table 1, Table 2 and Table 3 in the narrative text. A descriptive-analytical method was utilized to present a narrative account of the existing literature. Data-charting tables were developed to sort the extracted data and included charting of key features. The tables include the geographical distribution of studies, research methods, dimensions and measures of screening behavior, race/ethnicity of participants, and major findings; the studies are listed in the chronological order of publication date, from the earliest to the most recent publication.

3. Results

3.1. Search Results

The final articles about ADRD screening or diagnosis behavior, and factors associated with screening behavior were analyzed. The final articles were organized into study locations, designs, sampling, race/ethnicity and language, and major findings of dementia screening behavior (Table 1). In order to provide structure and meaning to the results, we created thematic frameworks [23]. Three frameworks were created including study characteristics, dimensions of ADRD screening behaviors, and ADRD screening behaviors by race/ethnicity.

3.2. Study Designs

Table 1 presents the quantitative, mixed-methods, and qualitative studies. Among the quantitative studies, five studies used the existing national health survey data or Medicare/Medicaid data. No experimental studies were included. As can be seen by reviewing Table 1, most studies were cross-sectional surveys that were conducted in the U.S. Various qualitative methods were used, including open-ended interviews, focus groups, grounded theory, semi-structured and in-depth interviews, and ethnography. The studies took place in the U.S. (n = 17) and Canada (n = 4). Race/ethnicities studied were: (1) Whites; (2) Blacks; (3) Hispanics; (4) Asian Americans; (5) Native Americans; and (6) others. Subgroups of Blacks were African Americans and Caribbean Blacks, subgroups of Whites were non-Hispanic Whites and French-speaking Whites, and subgroups of Asian Americans were Chinese, Korean, South Asian, Indian, and Sri Lankan.

3.3. Sample Characteristics

The most frequently studied ethnic group was Blacks (n = 14), followed by Asians (n = 7) and non-white Latinos (n = 6) ethnic groups. Two studies covered Native Americans [34,36]. All areas, urban (n = 11), suburban (n = 4), and rural (n = 4), were included. Fourteen papers studied patients or people with and without dementia in their research. Nine papers involved only patients, and five studies involved both patients and family caregivers as dyads. Patients with or without dementia were the largest group of participants in the identified studies. In terms of settings of the studies, 17 studies were conducted in the U.S., and four in Canada. Subjects were recruited from clinics, community-based clinics, or community organizations. All primary quantitative studies recruited the participants in person through the partner agencies’ networks, phone calls, advertising materials (e.g., flyers, newspapers, and social media). Five studies utilized the existing population-based national data about health insurance (e.g., the National Health and Aging Trends Study (NHATS) and California Medicare fee-for-service data) or older adults’ economic, health, and psychosocial information (e.g., the Health and Retirement Study (HRS)). Of the five, three studies utilized a combination of in-person and online recruitment methods such as email [39,40] and social media [33]. Potential participants were recruited by referral from local community centers, physician offices, churches, senior centers, and memory disorder clinics. Only two studies [32,35] included a report of the response rate, and one study [35] included a report of response rates below 7.5%. As this study focused on North America, most studies (n = 12) used English, except for seven studies without language information for the recruitment or data collection. Of the 12, five studies reported “English-speaking” as an inclusion criterion. Seven studies used both English and other minorities’ languages, such as Spanish (n = 4), Korean (n = 1), Chinese (n = 1), and Hindi (n = 1). Two studies used only the language of their target population, French or Chinese.

3.4. Theoretical Trends

Most quantitative studies were conducted without theoretical frameworks. Only two cross-sectional studies [33,36] used theoretical frameworks: a modified version of the Integrated Behavior Model [36], and a conceptual framework were developed based on the attitude theories focusing on stigma beliefs and subjective norms of AD care among Korean Americans [33]. Two qualitative [43,45] and one mixed-methods [39] studies used health belief models or a health-seeking model to explore the perception of dementia screening and to explain the rationale for dementia screening-seeking behaviors among ethnically diverse patients, family caregivers, and stakeholders. According to the Kaleidoscope Model of Health Communication, Garcia and others’ study [47] looked at health communication between HCPs and French-speaking patients, especially people with dementia who reverted to their primary languages among Francophones.

3.5. ADRD Screening Behavior Is A Multidimensional Construct

We have found that two terms of AD and dementia are often used interchangeably in the study and practice; however, AD is preferred more than dementia because patients more readily understand the term [30]. Hence, the term ADRD screening behavior will be used in this paper for dementia and AD screening behavior. The literature revealed that ADRD screening behavior is a multidimensional construct including both subjective perception and objective screening action, specifically, dimensions of noticing symptoms, recognizing a problem, accepting screen, intending to screen, action, and integrating with time (Table 2). ADRD screening behavior is integrated with time as it is defined as delayed, timely, or early screenings. Most studies focused on recognition of the problem (n = 6), acceptance or intention (n = 4) to do screening of ADRD, and actual ADRD screening (n = 4). The empirical statements for each dimension extracted from the included studies were summarized and are compared in Table 2.
Though the phenomenon of ADRD screening behavior is on a continuum, and it is not static, most quantitative studies utilized cross-sectional design and typically examined associations between screening behavior and its correlates as static. Qualitative [42,43,44,45,46,47] studies addressed that dementia screening behavior is not static and that it is fluid, and screening pathways which were multiple stages of the screening process were identified by examining and reporting recognition of dementia symptoms, making lay diagnosis or awareness of the problem, intention to screening, and then taking screening examinations. However, some people can move back and forth along the pathways. Koehn and others [45] stated that most Chinese Canadian caregivers described a process of gradually piecing together the rationale to explain their spouses’ or parents’ “puzzling behaviors”, and Leung and others [44] described that none of the Euro-Canadian participants identified any critical event, but rather a gradual memory decline when asked what triggered their desire to seek care. However, once Chinese Canadian caregivers realized that the symptoms and behaviors were “problematic”, they quickly sought additional information, usually from a family physician [45].
As for measurements, there is limited information assessing the multidimensional and time-bounded pheromone of ADRD seeking behavior. There is an absence of a commonly agreed-upon approach to assess ADRD seeking behavior, as shown in Table 2. In general, dementia screening behaviors were measured based on a focus on the types of dimensions of the construct of screening behavior that they were interested in studying (Table 2). Most measures were developed by authors for their studies or revised the existing tools which measured similar concepts [29,31,33,36,39]. For instance, the PRISM-PC questionnaire, which is most often used [30,31,39,40], consists of two separate scales: the patient’s acceptance of the dementia screening scale and the patient’s perceived harms and benefits of the dementia screening scale. The measure of action included both whether ADRD screening/diagnosis was missed or delayed [37], or screened/diagnosed ADRD involved the use of clinical interviews and previously standardized and/or validated assessment criteria [7,34,35,38]. Missed/delayed screening/diagnosis were usually assessed using the proportion of patients or people within the research settings who were considered to have ADRD but who were not diagnosed by their physicians or had no information in their medical records. Five of 17 quantitative studies used the existing population-based data in conjunction with Medicare and Medicaid data [7,32,34,37,38]. Regarding screening behavior integrated with timing, the interval was measured from noticing or recognition of symptoms of dementia either by patients, caregivers, or HCPs to first contacting a physician or actual screening. The term “Delay” is often used to report the intervals that were reported in days or months and categorized into two delays: delay before recognizing the problem of symptoms and delay before patients or caregivers contact physicians [28]. The time interval or delay was measured in months, and reported delay times before recognizing problems of symptoms and before physician consultation was 0 to 84 months and 0.1 to 84 months, respectively [28].

3.6. Differences in ADRD Screening Behavior among Ethnicities

We first provide comparative summaries on awareness, intention, and action of screening and diagnosis among minority ethnic groups (Table 3). We then summarize the quantitative reports about African Americans/Blacks, Hispanics/Latinos, and Asian American groups. Several studies either reported on individual ethnic groups, in aggregate or multiple ethnic groups. The majority of studies reported that minority groups had low awareness, intention, and diagnosis, compared to non-Hispanic White reference groups [7,31,37,41]. Differences between minority ethnic groups were more evident from population-based research than from clinic-based or community-based studies (Table 1 and Table 3). For example, Gianattasio et al. [7] reported that Blacks had double the risk of being underdiagnosed compared with Whites in all six observations (RRs = 1.58–2.4) based on the Health Retirement Study (N = 29,775; 2000 to 2010). Similarly, Tsoy et al. (2021) [38] used a large data set of 2013–2015 California Medicare fee-for-services (N = 10,472) and found low ORs for receiving a timely diagnosis among Asians (OR = 0.46; 95% CI = 0.38–0.56), Blacks (OR = 0.73; 95% CI = 0.56–0.94), or Hispanics (OR = 0.62; 95% CI = 0.52–0.72) compared to Whites. Asians (incidence RR = 0.81; 95% CI = 0.74–0.87) also received fewer diagnostic evaluations, and these associations remained significant after adjusting for age, sex, comorbidity burden, neighborhood disadvantage, and rurality.
Among six qualitative studies, four were reported from Canada, of which three reported on Chinese, South Asian, and French-speaking groups [45,46,47]. Most qualitative studies explored experiences in the perception of noticing symptoms and how recognizing symptoms as problematic translated into making a lay diagnosis to seek medical attention from patients, family, and stakeholders. Though there are multiple pathways of the screening process from noticing symptoms to having been screened, no ethnic-specific pathways were reported. Rather, there is a general trend that, at the first notice of symptoms, most participants, regardless of their ethnicity and whether they are patients or family members, considered it as a normal aging process or temporary episodes. However, among Chinese, South Asian, and French-Canadian subgroups, themes of cultural communication emerged and were linked with delayed diagnosis. The following quotes illustrate the point:
“He recalls that his mother’s doctor, who practices in Chinatown, said, ‘don’t expect too much… it is like a machine. After a long period of time, its parts will certainly be off or fall apart.’ The son denies that his mother has ever received a formal diagnosis of AD or dementia. He wishes that the doctor would ‘explain more’ and emphasized language barriers as a significant problem in getting care for his mother.”
[42] (p. 140)
In another study, they pointed to the fact that they would like to have physicians who speak the same ethnic language even though they speak English. “He (patient) lost a lot of his English…we had settled down for good…, there was the possibility of getting a doctor in French” [47] (p. 972). They were waiting for a physician who could communicate in French, which is one of the reasons for the delay in screening. In addition, in the Asian, Chinese subgroup, a stigma theme emerged: “I think my family did not have this before. I thought that when people got old, they would be forgetful, talked silly and sometimes insane. It is not a disease, but a natural course of life…because in old age, it is like that -it should be crazy (Shu*)” [45] (p. 49).

4. Discussion

With no effective treatment to prevent or modify the disease course, AD is an immense burden on our economy, patients, and caregivers; hence, early screening of ADRD based on early recognition of the problem of symptoms and caregivers’ concerns is critical to identify reversible etiologies and reduce patient and caregiver burden. This paper has performed a scope literature review of ADRD screening behavior focusing on ethnic minorities in North America since the racial/ethnicity factors that contribute to screening behavior are not well understood. The results point to the fact that there is a scarcity of studies focusing on describing ethnic-specific ADRD screening behavior as well as a lack of those examining the impact of ethnicities on ADRD screening behavior; especially, studies with Asian Americans are almost invisible. Although Asian Americans are the fastest-growing population in the U.S., ADRD research on Asian Americans is limited. It is reported that clinical research focused on Asian Americans and funded by the NIH only comprised 0.17% of its total budget based on 529 projects [48]. Although the goals of the 2012 National Plan to Address AD include strategies to diversify outreach in AD research [49], as observed in this review, investment and data for AD research on Asian Americans remain insufficient. As the incidence of ADRD increases significantly with age, especially among racial and ethnic minority groups, the fastest-growing population in the U.S., we believe our findings are very timely to exhort health policymakers and the scientific community to conduct more studies to enhance our understanding of this underserved and understudied population.
The most common first signs and symptoms noticed by the patient or others were memory loss, repeated questions, or word-finding problems, and the common cues to a willingness to screen were concerns about safety for patients, others, and the environment. These results are in agreement with two previous systematic literature reviews of non-ethnic group selected studies [17,20], suggesting that the association of concern about the safety of patients with prompting them to seek screening is generalizable. A lack of awareness, misunderstanding, access to healthcare resources, and stigma around ADRD combined with few treatment options are barriers to ADRD screening behavior. However, this conclusion could be incomplete due to the relatively small numbers of papers with heterogeneous designs with diverse racial/ethnic groups.
More racial and ethnic minorities were not aware of their cognitive symptoms, not talking to their HCP about their problems, were not being diagnosed, or among patients who were diagnosed, their family members were not informed by HCPs. These results align with previous findings from systemic literature reviews [50,51]. Both patients and caregivers emphasized that there were accumulated symptoms including memory problems, repeated questions, and a decline in judgment including handling checks and bank accounts, which implies that those symptoms could not be related to a single event. Previous literature has pointed out that non-ethnically matched HCPs’ misinterpretations of cultural behaviors might cause delayed diagnosis or misdiagnosis [52]. However, we did not find a positive impact of ethnically matched patients and HCPs on timely screening and cultural communication with caregivers from qualitative studies, which might be due to diversity within the racial/ethnic populations in North America. However, this finding suggests that HCPs will encounter more culturally diverse patients and there is no textbook for this encounter, but there is a need to study qualitatively and quantitatively racially and culturally diverse groups.

Strengths and Limitations

We included many search terms related to race/ethnicity and included both quantitative and qualitative methods. However, we only included studies conducted in North America and reviewed articles studying racial/ethnic minorities. The fact that only a few studies investigated Asian Americans in our report might be due to our decision to include only peer-reviewed articles. This review did not assess the methodological quality of the included studies as we reviewed both qualitative and quantitative methodologies. However, we think that this body of systematic scoping reviews provides important information that ADRD screening behavior is a multidimensional phenomenon, and it is not static but changes along the continuum of racial/ethnic minorities and that there is a lack of race/ethnicity-specific research, especially among immigrant minority populations. Health care and health research related to ADRD for immigrants is particularly challenging with the triple factors of low health literacy, cultural differences, and limited English proficiency [53], which would act as barriers to an effective screening of ADRD. As well, their impact on recruitment and how research is conducted should be addressed in health policy and research priority settings.
ADRD screening behavior in diverse populations may also be influenced by other sociodemographic factors including educational level, healthcare access, and relationships with healthcare professionals [26,32,33,35,40,42,47,53,54,55,56,57,58,59]. These factors might moderate the relationship between race/ethnicity and ADRD screening seeking behavior. For example, differences in educational attainment may account for the race-specific variability in screening seeking behavior [26,33,40]. Despite near-universal healthcare coverage through Medicare for seniors in the U.S, there are consistent reports of financial barriers to healthcare access, especially among racial/ethnic minority elders in the U.S. compared to Canada and other European countries [53,54]. In addition, racial/ethnic minorities may also have different perceptions and attitudes toward ADRD screening procedures than their White counterparts [55,56,57,58,59]. There exists evidence that Black adults mistrust the healthcare system and White healthcare providers because of a history of mistreatment as well as consistent racial disparities in health and health care [58,59,60]. Mistrust of healthcare providers or the healthcare system and being unable to communicate clearly with healthcare providers about their symptoms of dementia which are culturally bounded may lead to a great impact on ADRD screening seeking behavior. Exploring these sociocultural factors related to ADRD screening seeking behavior across cultures is a promising avenue for future research and we should pay more attention to addressing this problem.
Given that this review focused on studies conducted in the U.S. (English) and Canada (English/French), the language barrier is considered one of the main barriers to ADRD screening behavior in these monolingual countries. However, this observation might differ from countries where multiple languages are commonly spoken (e.g., in several European countries). Thus, our focus on the healthcare context in U.S. and Canada might limit the generalizability of our results.

5. Conclusions

A trend in ethnic disparities in screening for ADRD was observed. Timely detection of dementia is equally important as well as knowing the neuropathophysiological diagnosis. However, our findings point to the fact that there is a scarcity of studies focusing on describing ethnic-specific ADRD screening behavior as well as a lack of those examining the impact of ethnicity on ADRD screening behavior, especially studies where Asian Americans are almost invisible. We hope this article will ignite further inquiries to address how and what race–ethnic-related sociocultural factors such as education, healthcare access, health communication, and trusted healthcare providers have an influence on ADRD screening behavior and will impact health researchers, health policy makers, health practitioners, and stakeholders to be aware and to address the problems of ADRD screening seeking behaviors, especially among underserved and understudied racial–ethnic minority populations.

Author Contributions

Conceptualization, H.L.; methodology, H.L., D.K. and S.L.; analysis, D.K., S.L. and H.L; writing—original draft preparation, H.L. and S.L.; writing—review and editing, H.L. and S.L.; visualization, S.L. and D.K.; supervision, H.L. funding acquisition, H.L. All authors have read and agreed to the published version of the manuscript.

Funding

National Institute on Aging: R56AG069130.

Institutional Review Board Statement

The study did not require ethical approval.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Alzheimer’s Association. 2021 Alzheimer’s disease facts and figures. Alzheimers Dement. 2021, 17, 327–406. [Google Scholar] [CrossRef] [PubMed]
  2. Chodosh, J.; Petitti, D.B.; Elliott, M.; Hays, R.D.; Crooks, V.C.; Reuben, D.B.; Buckwalter, J.G.; Wenger, N. Physician recognition of cognitive impairment: Evaluating the need for improvement. J. Am. Geriatr. Soc. 2004, 52, 1051–1059. [Google Scholar] [CrossRef] [PubMed]
  3. Kotagal, V.; Langa, K.M.; Plassman, B.L.; Fisher, G.G.; Giordani, B.J.; Wallace, R.B.; Burke, J.R.; Steffens, D.C.; Kabeto, M.; Albin, R.L.; et al. Factors associated with cognitive evaluations in the United States. Neurology 2015, 84, 64–71. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Taylor Jr, D.H.; Østbye, T.; Langa, K.M.; Weir, D.; Plassman, B.L. The accuracy of Medicare claims as an epidemiological tool: The case of dementia revisited. J. Alzheimers Dis. 2009, 17, 807–815. [Google Scholar] [CrossRef] [Green Version]
  5. Dementias, Including Alzheimer’s Disease. Available online: https://www.healthypeople.gov/2020/topics-objectives/topic/dementias-including-alzheimers-disease/national-snapshot (accessed on 10 May 2022).
  6. Chin, A.L.; Negash, S.; Hamilton, R. Diversity and disparity in dementia: The impact of ethnoracial differences in Alzheimer’s disease. Alzheimer Dis. Assoc. Disord. 2011, 25, 187–195. [Google Scholar] [CrossRef] [Green Version]
  7. Gianattasio, K.Z.; Prather, C.; Glymour, M.M.; Ciarleglio, A.; Power, M.C. Racial disparities and temporal trends in dementia misdiagnosis risk in the United States. Alzheimers Dement. 2019, 5, 891–898. [Google Scholar] [CrossRef]
  8. Lang, L.; Clifford, A.; Wei, L.; Zhang, D.; Leung, D.; Augustine, G.; Danat, I.M.; Zhou, W.; Copeland, J.R.; Anstey, K.J.; et al. Prevalence and determinants of undetected dementia in the community: A systematic literature review and a meta-analysis. BMJ. Open 2017, 7, e011146. [Google Scholar] [CrossRef] [Green Version]
  9. Lines, L.M.; Wiener, J.M. Racial and Ethnic Disparities in Alzheimer’s Disease: A Literature Review. RTI International. 2014. Available online: https://aspe.hhs.gov/sites/default/files/migrated_legacy_files//138596/RacEthDis.pdf (accessed on 8 May 2022).
  10. Manly, J.J.; Avila, J.F.; Vonk, J.M.J.; Rentería, M.A.; Turney, I.C.; Lao, P.J.; Seblova, D.; Martinez, M.N.; Gutierrez, J.; Mayeux, R.; et al. Racial differences in cognitive resilience to parental history of AD and cognitive impairment: The offspring study. Alzheimers Dement. 2021, 17, e051874. [Google Scholar] [CrossRef]
  11. Special Committee on Aging United States Senate. 112th Congress 2d Session [Report 112–254]. Alzheimer’s Disease and Dementia: A Comparison of International Approaches. Available online: https://www.govinfo.gov/content/pkg/CRPT-112srpt254/pdf/CRPT-112srpt254.pdf (accessed on 8 May 2022).
  12. Cooper, C.; Tandy, A.R.; Balamurali, T.B.S.; Livingston, G. A systematic review and meta-analysis of ethnic differences in use of dementia treatment, care, and research. Am. J. Geriatr. Psychiatry 2010, 18, 193–203. [Google Scholar] [CrossRef]
  13. Livney, M.G.; Clark, C.M.; Karlawish, J.H.; Cartmell, S.; Negrón, M.; Nuñez, J.; Xie, S.X.; Entenza-Cabrera, F.; Vega, I.E.; Arnold, S.E. Ethnoracial differences in the clinical characteristics of Alzheimer’s disease at initial presentation at an urban Alzheimer’s disease center. Am. J. Geriatr. Psychiatry 2011, 19, 430–439. [Google Scholar] [CrossRef] [Green Version]
  14. National Plan to Address Alzheimer’s Disease: 2021 Update. Available online: https://aspe.hhs.gov/reports/national-plan-2021-update (accessed on 10 May 2022).
  15. Colby, S.L.; Ortman, J.M. Projections of the Size and Composition of the U.S. Population: 2014 to 2060, Current Population Reports, P25-1143; U.S. Census Bureau: Washington, DC, USA, 2014.
  16. Babulal, G.M.; Quiroz, Y.T.; Albensi, B.C.; Arenaza-Urquijo, E.; Astell, A.J.; Babiloni, C.; Bahar-Fuchs, A.; Bell, J.; Bowman, G.L.; Brickman, A.M.; et al. Perspectives on ethnic and racial disparities in Alzheimer’s disease and related dementia: Update and areas in immediate need. Alzheimers Dement. 2019, 15, 292–312. [Google Scholar] [CrossRef] [PubMed]
  17. Dubois, B.; Padovani, A.; Scheltens, P.; Rossi, A.; Dell’Agnello, G. Timely diagnosis for Alzheimer’s disease: A literature review on benefits and challenges. J. Alzheimers Dis. 2016, 49, 617–631. [Google Scholar] [CrossRef] [Green Version]
  18. Ford, M.E.; Kelly, P.A. Conceptualizing and categorizing race and ethnicity in health services research. Health Serv. Res. 2005, 40, 1658–1675. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  19. Herrmann, L.K.; Welter, E.; Leverenz, J.; Lerner, A.J.; Udelson, N.; Kanetsky, C.; Sajatovic, M. A systematic review of dementia-related stigma research: Can we move the stigma dial? Am. J. Geriatr. Psychiatry 2018, 26, 316–331. [Google Scholar] [CrossRef] [PubMed]
  20. Marin, S.; Kelly, S.; Khan, A.; Cullum, S.; Dening, T.; Rait, G.; Fox, C.; Katona, C.; Cosco, T.; Brayne, C.; et al. Attitudes and preferences towards screening for dementia: A systematic review of the literature. BMC Geriatr. 2015, 15, 66. [Google Scholar]
  21. Sagbakken, M.; Spilker, R.S.; Nielsen, T.R. Dementia and immigrant groups: A qualitative study of challenges related to identifying, assessing, and diagnosing dementia. BMC Health Serv. Res. 2018, 18, 910. [Google Scholar] [CrossRef]
  22. Quiroz, Y.T.; Solis, M.; Aranda, M.P.; Arbaje, A.I.; Arroyo-Miranda, M.; Cabrera, L.Y.; Carrasquillo, M.M.; Corrada, M.M.; Crivelli, L.; Diminich, E.D.; et al. Addressing the disparities in dementia risk, early detection and care in Latino populations: Highlights from the second Lationos & Alzheimer’s symposium. Alzheimers Dement. 2022, 1–10. [Google Scholar] [CrossRef]
  23. Tricco, A.C.; Lillie, E.; Zarin, W.; O’Brien, K.K.; Colquhoun, H.; Levac, D.; Moher, D.; Peters, M.D.J.; Horsley, T.; Weeks, L.; et al. PRISMA extension for scoping reviews (PRISMA-ScR): Checklist and explanation. Ann. Intern. Med. 2018, 169, 467–473. [Google Scholar] [CrossRef] [Green Version]
  24. Arksey, H.; O’Malley, L. Scoping studies: Towards a methodological framework. Int. J. Soc. Res. Methodol. 2005, 8, 19–32. [Google Scholar] [CrossRef] [Green Version]
  25. Lee, H.; Fawcett, J.; Kim, D.; Yang, J.H. Correlates of hepatitis B virus-related stigmatization experienced by Asians: A scoping review of literature. Asia Pac. J. Oncol. Nurs. 2016, 3, 324–334. [Google Scholar] [CrossRef]
  26. Lim, S.; Chong, S.; Min, D.; Mohaimin, S.; Roberts, T.; Trinh-Shevrin, C.; Kwon, S.C. Alzheimer’s disease screening tools for Asian Americans: A scoping review. J. Appl. Gerontol. 2021, 40, 1389–1398. [Google Scholar] [CrossRef] [PubMed]
  27. Pham, M.T.; Rajić, A.; Greig, J.D.; Sargeant, J.M.; Papadopoulos, A.; McEwen, S.A. A scoping review of scoping reviews: Advancing the approach and enhancing the consistency. Res. Synth. Methods 2014, 5, 371–385. [Google Scholar] [CrossRef] [PubMed]
  28. Clark, P.C.; Kutner, N.G.; Goldstein, F.C.; Peterson-Hazen, S.; Garner, V.; Zhang, R.; Bowles, T. Impediments to timely diagnosis of Alzheimer’s disease in African Americans. J. Am. Geriatr. Soc. 2005, 53, 2012–2017. [Google Scholar] [CrossRef] [PubMed]
  29. Holsinger, T.; Boustani, M.; Abbot, D.; Williams, J.W. Acceptability of dementia screening in primary care patients. Int. J. Geriatr. Psychiatry 2011, 26, 373–379. [Google Scholar] [CrossRef] [PubMed]
  30. Fowler, N.R.; Boustani, M.A.; Frame, A.; Perkins, A.J.; Monahan, P.; Gao, S.; Sachs, G.A.; Hendrie, H.C. Impact of patients’ perceptions on dementia screening in primary care. J. Am. Geriatr. Soc. 2012, 60, 1037–1043. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  31. Fowler, N.R.; Perkins, A.J.; Turchan, H.A.; Frame, A.; Monahan, P.; Gao, S.; Boustani, M.A. Older primary care patients’ attitudes and willingness to screen for dementia. J. Aging Res. 2015, 2015, 423265. [Google Scholar] [CrossRef] [PubMed]
  32. Savva, G.M.; Arthur, A. Who has undiagnosed dementia? A cross-sectional analysis of participants of the Aging, Demographics and Memory Study. Age Ageing 2015, 44, 642–647. [Google Scholar] [CrossRef] [Green Version]
  33. Casado, B.L.; Hong, M.; Lee, S.E. Attitudes toward Alzheimer’s care-seeking among Korean Americans: Effects of knowledge, stigma, and subjective norm. Gerontologist 2018, 58, e25–e34. [Google Scholar] [CrossRef] [Green Version]
  34. Amjad, H.; Roth, D.L.; Sheehan, O.C.; Lyketsos, C.G.; Wolff, J.L.; Samus, Q.M. Underdiagnosis of dementia: An observational study of patterns in diagnosis and awareness in US older adults. J. Gen. Intern. Med. 2018, 33, 1131–1138. [Google Scholar] [CrossRef] [Green Version]
  35. Harrawood, A.; Fowler, N.R.; Perkins, A.J.; LaMantia, M.A.; Boustani, M.A. Acceptability and results of dementia screening among older adults in the United States. Curr. Alzheimer Res. 2018, 15, 51–55. [Google Scholar] [CrossRef]
  36. Park, J.; Tolea, M.; Besser, L.; Galvin, J. Intention to be screened for Alzheimer’s disease in nondemented older adults: Integrated Behavioral Model and self-efficacy as mediation effect. J. Hum. Behav. Soc. Environ. 2020, 30, 778–796. [Google Scholar] [CrossRef] [PubMed]
  37. Lin, P.; Daly, A.T.; Olchanski, N.; Cohen, J.T.; Neumann, P.J.; Faul, J.D.; Fillit, H.M.; Freund, K.M. Dementia diagnosis disparities by race and ethnicity. Med. Care 2021, 59, 679–686. [Google Scholar] [CrossRef]
  38. Tsoy, E.; Kiekhofer, R.E.; Guterman, E.L.; Tee, B.L.; Windon, C.C.; Dorsman, K.A.; Lanata, S.C.; Rabinovici, G.D.; Miller, B.L.; Kind, A.J.H.; et al. Assessment of racial/ethnic disparities in timeliness and comprehensiveness of dementia diagnosis in California. JAMA Neurol. 2021, 78, 657–665. [Google Scholar] [CrossRef] [PubMed]
  39. Wiese, L.K.; Galvin, J.E.; Williams, C.L. Rural stakeholder perceptions about cognitive screening. Aging Ment. Health 2019, 23, 1616–1628. [Google Scholar] [CrossRef] [PubMed]
  40. Wiese, L.K.; Williams, I.; Williams, C.L.; Galvin, J.E. Discerning rural Appalachian stakeholder attitudes toward memory screening. Aging Ment. Health 2021, 25, 797–806. [Google Scholar] [CrossRef] [PubMed]
  41. Williams, C.L.; Tappen, R.M.; Rosselli, M.; Keane, F.; Newlin, K. Willingness to be screened and tested for cognitive impairment: Cross-cultural comparison. Am. J. Alzheimers Dis. Other Demen. 2010, 25, 160–166. [Google Scholar] [CrossRef]
  42. Hinton, L.; Franz, C.; Friend, J. Pathways to dementia diagnosis: Evidence for cross-ethnic differences. Alzheimer Dis. Assoc. Disord. 2004, 18, 134–144. [Google Scholar] [CrossRef]
  43. Hugh, T.; Tyler, K.; Danner, D.; Carter, A. African American caregivers: An exploration of pathways and barriers to a diagnosis of Alzheimer’s disease for a family member with dementia. Dementia 2009, 8, 95–116. [Google Scholar] [CrossRef]
  44. Leung, K.K.; Finlay, J.; Silvius, J.L.; Koehn, S.; McCleary, L.; Cohen, C.A.; Hum, S.; Garcia, L.; Dalziel, W.; Emerson, V.F.; et al. Pathways to diagnosis: Exploring the experiences of problem recognition and obtaining a dementia diagnosis among Anglo-Canadian. Health Soc. Care Community 2011, 19, 372–381. [Google Scholar] [CrossRef]
  45. Koehn, S.; McCleary, L.; Garcia, L.; Spence, M.; Jarvis, P.; Drummond, N. Understanding Chinese-Canadian pathways to a diagnosis of dementia through a critical-constructionist lens. J. Aging Res. 2012, 26, 44–54. [Google Scholar] [CrossRef]
  46. McCleary, L.; Persaud, M.; Hum, S.; Pimlott, N.J.G.; Cohen, C.A.; Koehn, S.; Leung, K.K.; Dalziel, W.B.; Kozak, J.; Emerson, V.F.; et al. Pathways to dementia diagnosis among South Asian Canadians. Dementia 2013, 12, 769–789. [Google Scholar] [CrossRef] [PubMed]
  47. Garcia, L.J.; McCleary, L.; Emerson, V.; Léopoldoff, H.; Dalziel, W.; Drummond, N.; Cohen, C.; Koehn, S.; Silvius, J. The pathway to diagnosis of dementia for Francophones living in a minority situation. Gerontologist 2013, 54, 964–975. [Google Scholar] [CrossRef] [PubMed]
  48. Doàn, L.N.; Takata, Y.; Sakuma, K.K.; Irvin, V.L. Trends in clinical research including Asian American, Native Hawaiian, and Pacific Islander participants funded by the US National Institutes of Health, 1992 to 2018. JAMA Netw. Open 2019, 2, e197432. [Google Scholar] [CrossRef] [PubMed]
  49. NIA and the National Plan to Address Alzheimer’s Disease. Available online: https://www.nia.nih.gov/about/nia-and-national-plan-address-alzheimers-disease (accessed on 8 May 2022).
  50. Bradford, A.; Kunik, M.E.; Schulz, P.; Williams, S.P.; Singh, H. Missed and delayed diagnosis of dementia in primary care: Prevalence and contributing factors. Alzheimer Dis. Assoc. Disord. 2009, 23, 306–314. [Google Scholar] [CrossRef] [PubMed]
  51. Romano, R.R.; Carter, M.A.; Anderson, A.R.; Monroe, T.B. An integrative review of system-level factors influencing dementia detection in primary care. J. Am. Assoc. Nurse Pract. 2020, 32, 299–305. [Google Scholar] [CrossRef] [PubMed]
  52. Elliott, K.S.; Di Minno, M. Unruly grandmothers, ghosts and ancesters: Chinese elders and the importance of culture in dementia evaluations. J. Cross Cult. Gerontol. 2006, 21, 157–177. [Google Scholar] [CrossRef]
  53. Sentell, T.; Braun, K. Low health literacy, limited english proficiency, and health status in asians, latinos, and other racial/ethnic groups in California. J. Health Commun. 2012, 17 (Suppl. S3), 82–99. [Google Scholar] [CrossRef] [Green Version]
  54. Angel, J.L.; Angel, R.J. Minority group status and healthful aging: Social structure still matters. Am. J. Public Health. 2006, 96, 1152–1159. [Google Scholar] [CrossRef]
  55. Osborn, R.; Doty, M.M.; Moulds, D.; Sarnak, D.O.; Shah, A. Older Americans Were Sicker and Faced More Financial Barriers to Health Care than Counterparts in Other Countries. Health Aff. 2017, 36, 2123–2132. [Google Scholar] [CrossRef] [Green Version]
  56. Jones, R.S.; Chow, T.W.; Gatz, M. Asian Americans and Alzheimer’s disease: Assimilation, culture, and beliefs. J. Aging Stud. 2006, 20, 11–25. [Google Scholar] [CrossRef]
  57. Roche, M.; Higgs, P.; Aworinde, J.; Cooper, C. A Review of Qualitative Research of Perception and Experiences of Dementia Among Adults from Black, African, and Caribbean Background: What and Whom Are We Researching? Gerontology 2021, 61, e195–e208. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  58. Judge, D.; Roberts, J.; Khandker, R.; Ambegaonkar, B.; Black, C.M. Physician Perceptions about the Barriers to Prompt Diagnosis of Mild Cognitive Impairment and Alzheimer’s Disease. Int. J. Alzheimers Dis. 2019, 21, 3637954. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  59. Alsan, M.; Wanamaker, M. Tuskegee and the Health of Black Men. Q. J. Econ. 2018, 133, 407–455. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  60. Alsan, M.; Owen Garrick, O.; Graziani, G. Does Diversity Matter for Health? Experimental Evidence From Oakland. Am. Econ. Rev. 2019, 109, 4071–4111. [Google Scholar] [CrossRef] [Green Version]
Figure 1. Study Flowgram.
Figure 1. Study Flowgram.
Ijerph 19 08865 g001
Table 1. Study characteristics and findings.
Table 1. Study characteristics and findings.
ReferencesStudy Location/
Recruitment Sites/
Age Range
Design/Population/
Sample Size
Ethnicity/Race/
Language
Key Findings
Clark
et al.
(2005)
[28]
U.S.
Community-based clinics (urban and suburban)
Cohort study
Patients with probable AD and primary family caregivers
n = 79 units
African AmericansTime from noticing first AD signs to recognition
  • No difference urban vs. suburban
(Median 9 months (range 1–84) vs. 6 months (0–72))
Time from recognition to physician consultation:
  • No difference urban vs. suburban
(Median 3 months (0.2–84) vs. 2 months (0.1–48))
Longer delay in recognition associated with longer delay in physician consultation
Holsinger
et al.
(2011)
[29]
U.S.
2 sites: Clinics and community-based clinics (urban)
≥50 years
Cross-sectional study
Patients presenting for primary care appointments
n = 345
White vs. minority
Site 1 (n = 152): White 73%
Site 2 (n = 193): White 57%
Majority accepted screening
After exposing various potential risks and benefits, more accepted screening.
No difference between white and minority
Fowler
et al.
(2012)
[30]
U.S.
Community-based clinics (urban)
≥65 years
Cross-sectional study
Patients with no dementia receiving primary care
n = 554
White 41.5%, African Americans 56.5%
Other 1.4%
Majority willing to screen; 12.7% screened positive
Refusal rates did not vary with ethnicity, education, other SES.
Odds of refusal higher in older age groups
Fowler
et al.
(2015)
[31]
U.S.
2 sites
Clinic (urban) and community-based clinics (urban and suburban)
≥65 years
Cross-sectional study
Patients with no dementia receiving primary care
n = 400
Site 1 (n = 278): White 78.1%, African American 20.9%, Other 1.1%
Site 2 (n = 122): White 96.7%, African American 2.5%, Other 0.8%
English
Site 1:
No difference in acceptance and refusal between White and African Americas
Site 2: only one African American participant
No differences in refusal between two sites
Perceptions about the benefits of screening associated with acceptance of screening
No effect of sociodemographic data except education predicted acceptance
Savva
et al.
(2015)
[32]
U.S.
Nationwide
≥71 years
Cross-sectional study
Patients with dementia
Data source: ADAMS substudy from HRS
2000–2002 waves
n = 307
White 73%, Non-White 27%
English or Spanish
121 informants reported prior diagnosis
Grater CDC rate associated with prior diagnosis
Race or nursing home residency no link with prior diagnosis
Aged <90 years or married women associated with prior diagnosis.
¾ undiagnosed have mild dementia
Casado
et al.
(2017)
[33]
U.S.
Community (community outreach, local business sites, flyers, newsletters, social media)
≥40 years
Cross-sectional survey
Adults
n = 234
Korean Americans
English or Korean
20.7% reported having experience with caring for someone with AD.
Attitude scores were slightly more positive toward AD specialists (mean = 55.92 ± 7.40) than toward PCPs (mean = 54.24 ± 9.82).
Amjad
et al.
(2018)
[34]
U.S.
Nationwide
≥65 years
Cross-sectional observational study
Patients with probable dementia or proxy
Data source: NHATS
n = 585
Non-Hispanic White, non-Hispanic Black, Hispanic or other non-Hispanic (Asian, Pacific Islander, and Native American)39.5% undiagnosed
Among diagnosed, 31% of those persons or their proxies were unaware of diagnosis.
Undiagnosed persons likely to be non-White and lower education.
But OR was statistically significant only for Hispanic/other non-White race
Majority of older adults with dementia either undiagnosed or unaware of the diagnosis
Harrawood
et al.
(2018)
[35]
U.S.
3 sites: clinic (urban) and community-based clinics (urban and suburban)
≥65 years
Cross-sectional study
Patients with no dementia receiving primary care
n = 954
African American 42.4% (n = 317): Site 1 (n = 280), Site 2 (n = 35), Site 3 (n = 2)21.6% refused screening
78.4% agreed to be screened
10.2% screened positive: 11.7% African American; 9.0% White and other
Older age (>75 years) low education, and perceived problem with memory associated with screening positive but no effect from race and research sites.
Gianattasio
et al.
(2019)
[7]
U.S.
Nationwide
≥70 years
Longitudinal study
Patients with dementia
Data source: HRS biannual interviews with participants or proxy linked with Medicare claims
n = 4647–5201 (2000 to 2010, 6 observations)
Non-Hispanic White: 91–93%, Non-Hispanic Black: 7–9%
English or Spanish
Whites were “correctly diagnosed”
Blacks were “underdiagnosed”
Black had double the risk of underdiagnosed compare with White at all 6 waves
Risk of over diagnosed increased over time in both groups
Park
et al.
(2020)
[36]
U.S.
Community (urban, suburban, and rural)
>50 years
Cross-sectional study
Individuals with no dementia
n = 1043
White 82.7%, Black/African American 11.6%, Hispanic 1.2%, Asian 0.6%, Native Hawaiian/Pacific Islander 0.3%, American Indian 0.8%
English
In terms of demographic difference, female and participants with long-term care insurance have greater intention to screen but no mention about the effect of race.
Younger age, higher level of perceived barriers, perceived benefit, higher social support and self-efficacy associated with increased intention
Lin
et al.
(2021)
[37]
U.S.
Nationwide
≥70 years
Prospective cohort study
Patients with probable dementia
Data source: HRS 2000–2014 linked with Medicare and Medicaid
n = 3966
Non-Hispanic White 80.8%, non-Hispanic Black 11.9%, Hispanic 7.3%
English or Spanish
A higher proportion of Blacks and Hispanics had a missed/delayed clinical dementia diagnosis compared with White (46%, s = 54% vs. 41%)
Blacks and Hispanics had a poorer cognitive function and more functional limitations than White when received dementia diagnosis.
  • Estimated mean delay:
Blacks: 34.6 months; Hispanic 43.8 months; White: 31.2 months
Tsoy
et al.
(2021)
[38]
U.S.
Statewide
Retrospective cross-sectional study
Patients with no prior dementia or MCI
Data source: California CMS claims 2013–2015
n = 10,472
White 74.6%, Black 3.9%, Hispanic 12.0%, Asian 9.5%Incident MCI diagnosis
23.3% White, 18.28% Black, 12.3% Asian, 15.8% Hispanic
Timeliness of diagnosis
Asian, Blacks, and Hispanic less likely to receive an incident diagnosis of MCI vs. dementia than White
Estimated mean marginal effects of race/ethnicity on incident diagnosis of MCI were −11.0% for Asian, −6.6% for Hispanic, and −5.6% for Black
Wiese
et al.
(2019)
[39]
U.S.
Local service organizations, physician offices, church councils, senior center (rural)
Mixed methods
Stakeholders
-Social workers, healthcare administrators, nurses, nurses’ aides, physician, ministers, clerical worker, kitchen aids, farmworkers, auto mechanic, church worker
n = 21
Non-Hispanic White (n = 5): professionals 4, layperson 1
African American (n = 11): professionals 9, laypersons 2
Afro-Caribbean
(n = 2): professional 1, layperson 1
Hispanic American (n = 2): professional 1, layperson 1
English
81%: willing to screening annually if they developed memory problems or AD
85% of those previously screened would want to know if they were at higher risk of AD.
Wiese
et al.
(2021)
[40]
U.S.
Local city hall, senior centers, healthcare clinics, faith-based organizations (rural)
Mixed methods
Stakeholders
-Senior center administrators, senior center volunteer staffs, health clinic administrators, law enforcement officers, emergency medical technicians, physicians, nurse practitioners, nurses, paid caregivers, family caregivers, residents
n = 22
White (n = 21), African American (n = 1)
English
100%: willing to screening
82%: agreeable to blood testing
86%: agreeable to pictures of head or brain to detect dementia
All would want their provider to screen them annually for memory problems
Williams
et al.
(2010)
[41]
U.S.
Churches, senior centers, health fair (announcements and flyers)
Mixed method
Open-ended questions
A part memory screening study of 793 community dwelling older adults
n = 119
African American (n = 26)
Afro-Caribbean (n = 31)
European American (n = 29)
Hispanic American (n = 33)
English or Spanish
More African Americans recruited from churches than Hispanic and European American
89% valued the screening
92% would recommend screening to others
39% would seek professional help if they screened positive.
More Hispanic Americans (70%) planned to seek help than did than European Americans (35%), African Americans (31%), or Afro-Caribbean (16%).
Hinton
et al.
(2004)
[42]
U.S.
Community (urban)
(Physician
referrals, Alzheimer’s Association, newspaper advertisements, etc.)
Caregiver to patient ≥50 years
Qualitative Study
In-depth interview
A part of Survey Study: 33% of 117 family caregivers to community dwelling dementia patients
-Wife, daughters, sons, others
n = 39
African American (n = 10)
Chinese American (n = 14)
Anglo European-American (n = 15)
English or three Chinese dialects (Mandarin, Cantonese, and Toisanese)
Help-seeking was most often initiated by family members or formal care providers
Lack of a final diagnosis: more commonly reported by Chinese Americans compared with Anglos and African Americans
Fragmentation in the referral process was common across all groups.
Four general types of pathways to diagnosis:
Smooth pathways/fragmented pathways/crisis pathways/dead-ended pathways
Hugh
et al.
(2009)
[43]
U.S.
Community
(urban and rural)
(A dementia outreach partnership)
Qualitative study
Face-to-face semi-structured interview
Health belief model
Family caregivers of dementia patients
-Daughters, spouses, sons, siblings
n = 17
African AmericanNot knowledgeable about AD prior to their family diagnosed
Knew that there is no known cure and expected a continued decline
Almost half attributed a change in cognition was normal, age-related memory loss
Some caregivers received support or resistance from other family member
A supportive social network facilitated a diagnosis.
Perplexing behavior and an increasing loss of ability are seen as cues to action
Leung
et al.
(2011)
[44]
Canada
Community and clinic (urban)
(Alzheimer’s Society, posters)
Patients: >55 years
Qualitative study
Semi-structured interview
Dyads of patients with dementia and family caregivers
-Caregivers: wives, daughter, son-in-law, husband
n = 6 dyads (7 caregivers)
Anglo-Canadian
English
Symptom recognition to a dementia diagnosis 2–4 years
Demented patients noticing memory difficulties earlier than careers but perceived as ambiguous and normalized or attributed to current health problem
Diagnosis process was multiple visits and interactions with health professionals, obtained as more severe cognitive deficit emerged
Koehn
et al.
(2012)
[45]
Canada
Community (urban)
(Chinese Resource Center of Alzheimer’s Society)
Qualitative study
Semi-structured interview
A Help-seeking Model
Dyads of patients with probable dementia and their careers
-Caregivers: wives, husband, daughter
n = 10 dyads
Chinese Canadian
Cantonese or Mandarin
The average pre-diagnosis interval: 1.5 years
Caregivers and patients reported a diversity of experiences regarding the early symptoms of the patients’ cognitive deficit.
Normalized of early symptoms
Decision to seek care was made by family member, either spouse or consulted with adult children
Two diagnosed done during acute care admission
The role of family caregivers was more influenced by structural factors than by traditional Chinese cultural norms about family responsibilities and filial piety.
60% of the dyads experienced delays in diagnosis because Chinese family doctors dismissed the caregivers’ appraisals of the patients’ symptoms. Gender-based power imbalance between female family caregivers and male Chinese Canadian physicians
McCleary et al. (2012)
[46]
Canada
Community (urban)
(Adult daycare center and flyers to community health center, local Alzheimer’s Society)
Patient: >70 years
Descriptive qualitative study
Semi-structured interview
Dyads of patients with dementia and either one or two of their family careers
-Caregivers: wives, daughters, daughter-in-law, husband, son, son-in-law
n = 6 dyads
South Asian-Canadian
English, Hindi, or Tamil
Early signs of dementia were seen as normal that are related to the aging process or patients’ personality characteristics.
Seek attention when dementia symptoms were worsened after episodes
Health seeking was delayed up to four years, even with significant dementia symptoms
Safety concerns, new symptoms, treatment for other health problem influenced the recognition of a health problem
Garcia
et al.
(2013)
[37]
Canada
Clinic setting
(a memory disorder clinic)
Patients: >60 years
Qualitative study
Semi-structured interview
Dyads of patients with dementia and family or friends
-Caregivers: spouses, daughters
n = 7 dyads
French-speaking Canadian
French
Estimated first suspicion of a problem to an official diagnosis: 1–7 years
Not easy to identify signs and symptoms
Lack of knowledge about the importance of the changes they were experiencing.
No single symptoms sufficient to alert participants
Preferentially sought from francophone
Recognition to consultation with family physician from 4 months to 6 years.
All final diagnoses were made by specialists, but family physicians clearly suspected dementia
Variety of reasons for the delay.
Abbreviations: AD, Alzheimer’s disease; ADAMS, Aging, Demographics and Memory Study; HRS, Health and Retirement Study; CDC, Centers for Disease Control and Prevention; PCP, primary care provider; NHATS, National Health and Aging Trends Study; OR, odds ratio; MCI, mild cognitive impairment; CMS, Centers for Medicare & Medicaid.
Table 2. Definitions and Measures of ADRD Screening Behavior.
Table 2. Definitions and Measures of ADRD Screening Behavior.
DimensionsDefinitionsFindings: Empirical StatementsMeasures/
Example Items
Noticing symptomsNoticing first signs and symptoms“I heard the word, but I did not pay much attention to it” Usually normalized or attribute to other health problems.
(Hugh et al. 2009) [43]
“The first ADRD symptoms were observed”
(Clark et al. 2005) [28]
Recognizing a problemRecognize the signs and symptoms as problemsMultiples signs and symptoms, more cognitive and behavior changes, symptoms getting worse and increasing loss of ability.
(McCleary et al. 2013) [46]
“Caregiver’s recognition that a problem existed”
(Clark et al. 2005) [28]
Accepting ScreenAcknowledging that there is a problem that needs to changeAccumulation of subtle changes including issues with hygiene, finance, or safety in combination with forgetfulness; Consider harm and benefit of screening.
(Garcia et al. 2013) [47]
Modified SAPH *
“I would like to know if I have a problem with my memory that may indicate that I’m developing dementia”
(Holsinger et al. 2011) [29]
Intending ScreenIntention or willingness undergo screen“No critical event either physical or cognitive symptoms to trigger their desire to seek care”
“Concerns safety is cue”
(Leung et al. 2011) [44]
“Plan to screen for AD at some point in life”
“Plan to screen for AD in the next year”
“Plan to screen for AD after the participant reaches a certain age”
“Plan to screen for AD in the presence of symptoms for AD”
(Park et al. 2020) [36]
ActionTaking actions to assess the symptomsDiagnosis process was multiple visits and interactions with health professionals.
(Leung et al. 2011) [44]
Ever participated in screen procedures
“Patients completed the MMSE, CSI-D, or TICS”
(Harrawood et al. 2018) [35]
Integrating with timeTimeliness of receiving a clinical diagnosis; Delays in diagnosis of ADRDDelays due to not only the trajectory of the disease and patients’ personality but also to the types of caregivers.
(Koehn et al. 2012) [45]
There was no single common pathway from recognition to action.
(McCleary et al. 2013) [46]
“The first observed ADRD symptoms to first physician visit”
(Clark et al. 2005) [28]
Abbreviations: ADRD, Alzheimer’s disease and related dementias; SAPH, Dementia Screening and Perceived Harms Questionnaire; PRISM-PC, Perceptions Regarding Investigational Screening for Memory in Primary Care; AD, Alzheimer’s disease; CSI-D, Community Screening Instrument for Dementia; TICS, Telephone Instrument for Cognitive Screening. * SAPH has become the PRISM-PC (Acceptance subscale: 2 dimensions, 6 items).
Table 3. ADRD screening behaviors by race/ethnicity.
Table 3. ADRD screening behaviors by race/ethnicity.
Non-Hispanic Black vs. White
SubgroupsFindings
ReferenceOutcomeValueReference Group
(Non-Hispanic White)
Non-Hispanic BlackFowler et al. (2015)
[31]
Accepted screening
Urban hospital60.3%63.1%
Network of urban and suburban hospitals and outpatient care centers66.3%63.6%
Folwer et al. (2012)
[30]
Undergo screening89.5%90.4%
Harrawood
et al.
(2018)
[35]
Screened positive for dementia11.7%9%
Lin et al., (2021)
[37]
Dementia diagnosis without delay54.5%59.3%
Missed or delayed dementia diagnosis45.5%40.8%
Amjad et al.
(2018)
[34]
Undiagnosed vs. diagnosed dementiaAdjusted OR 1.26 -
Unaware vs. aware of dementia diagnosisAdjusted OR 0.73
Gianattasio
et al.
(2019)
[7]
UnderdiagnosedAdjusted PR 1.35–2.33-
Hinton et al. (2004)
[42]
Lack of a final diagnosis20%7%
Latino/Hispanic vs. White
SubgroupsFindings
ReferenceOutcomeValueReference group (Non-Hispanic White)
HispanicLin et al.
(2021)
[37]
Dementia diagnosis without delay45.8%59.3%
Missed or delayed dementia diagnosis54.2%40.8%
Amjad et al.
(2018)
[34]
Undiagnosed vs. diagnosed dementiaAdjusted OR 2.48-
Unaware vs. aware of dementia diagnosisAdjusted OR 0.87 -
Asian vs. White
SubgroupFindings
ReferenceOutcomeValueReference group (Non-Hispanic White)
ChineseHinton et al. (2004)
[42]
Lack of a final diagnosis43%7%
Other vs. White
SubgroupFindings
ReferenceOutcomeValueReference group (Non-Hispanic White)
OtherFowler et al. (2015)
[31]
Accepted screening
Urban hospital33.3%63.1%
Network of urban and suburban hospitals and outpatient care centers100%63.6%
Fowler et al. (2012)
[30]
Undergo screening87.5%90.4%
Non-WhiteSavva
et al.
(2015)
[32]
Prior diagnosis of dementia (weighted)48%41.1%
“Other” racial groups are also included in the reference group. No statistical significance. Abbreviations: OR, odds ratio; PR, prevalence ratio.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Lee, S.; Kim, D.; Lee, H. Examine Race/Ethnicity Disparities in Perception, Intention, and Screening of Dementia in a Community Setting: Scoping Review. Int. J. Environ. Res. Public Health 2022, 19, 8865. https://doi.org/10.3390/ijerph19148865

AMA Style

Lee S, Kim D, Lee H. Examine Race/Ethnicity Disparities in Perception, Intention, and Screening of Dementia in a Community Setting: Scoping Review. International Journal of Environmental Research and Public Health. 2022; 19(14):8865. https://doi.org/10.3390/ijerph19148865

Chicago/Turabian Style

Lee, SangA, Deogwoon Kim, and Haeok Lee. 2022. "Examine Race/Ethnicity Disparities in Perception, Intention, and Screening of Dementia in a Community Setting: Scoping Review" International Journal of Environmental Research and Public Health 19, no. 14: 8865. https://doi.org/10.3390/ijerph19148865

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop